Role of the Transcription Factor MAFA in the Maintenance of Pancreatic β-Cells

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 May 14

PMID 35562869

Authors

Wataru Nishimura

Hiroaki Iwasa

Munkhtuya Tumurkhuu

Affiliations

Soon will be listed here.

Abstract

Pancreatic β-cells are specialized to properly regulate blood glucose. Maintenance of the mature β-cell phenotype is critical for glucose metabolism, and β-cell failure results in diabetes mellitus. Recent studies provide strong evidence that the mature phenotype of β-cells is maintained by several transcription factors. These factors are also required for β-cell differentiation from endocrine precursors or maturation from immature β-cells during pancreatic development. Because the reduction or loss of these factors leads to β-cell failure and diabetes, inducing the upregulation or inhibiting downregulation of these transcription factors would be beneficial for studies in both diabetes and stem cell biology. Here, we discuss one such factor, i.e., the transcription factor MAFA. MAFA is a basic leucine zipper family transcription factor that can activate the expression of insulin in β-cells with PDX1 and NEUROD1. MAFA is indeed indispensable for the maintenance of not only insulin expression but also function of adult β-cells. With loss of MAFA in type 2 diabetes, β-cells cannot maintain their mature phenotype and are dedifferentiated. In this review, we first briefly summarize the functional roles of MAFA in β-cells and then mainly focus on the molecular mechanism of cell fate conversion regulated by MAFA.

Citing Articles

A stepwise approach to deriving functional β-cells from human embryonic or induced pluripotent stem cells.

Farhat C, Xega V, Liu J Med Rev (2021). 2025; 5(1):23-34.

PMID: 39974557 PMC: 11834748. DOI: 10.1515/mr-2024-0039.

Reformed islets: a long-term primary cell platform for exploring mouse and human islet biology.

Haq N, Toczyska K, Wilson M, Jacobs M, Zhao M, Lei Y Cell Death Discov. 2024; 10(1):480.

PMID: 39580467 PMC: 11585622. DOI: 10.1038/s41420-024-02234-6.

Enhanced BMP Signaling Alters Human β-Cell Identity and Function.

Dekker E, Trinanes J, Munoz Garcia A, de Graaf N, de Koning E, Carlotti F Adv Biol (Weinh). 2024; 9(1):e2400470.

PMID: 39499224 PMC: 11760635. DOI: 10.1002/adbi.202400470.

Multi-omic human pancreatic islet endoplasmic reticulum and cytokine stress response mapping provides type 2 diabetes genetic insights.

Sokolowski E, Kursawe R, Selvam V, Bhuiyan R, Thibodeau A, Zhao C Cell Metab. 2024; 36(11):2468-2488.e7.

PMID: 39383866 PMC: 11798411. DOI: 10.1016/j.cmet.2024.09.006.

Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment.

Gojani E, Rai S, Norouzkhani F, Shujat S, Wang B, Li D Curr Issues Mol Biol. 2024; 46(7):7621-7667.

PMID: 39057094 PMC: 11275945. DOI: 10.3390/cimb46070453.

References

Aguayo-Mazzucato C, Koh A, El Khattabi I, Li W, Toschi E, Jermendy A . Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells. Diabetologia. 2010; 54(3):583-93. PMC: 3047400. DOI: 10.1007/s00125-010-2026-z. View

Trinanes J, Ten Dijke P, Groen N, Hanegraaf M, Porrini E, Rodriguez-Rodriguez A . Tacrolimus-Induced BMP/SMAD Signaling Associates With Metabolic Stress-Activated FOXO1 to Trigger β-Cell Failure. Diabetes. 2019; 69(2):193-204. DOI: 10.2337/db19-0828. View

Okauchi S, Shimoda M, Obata A, Kimura T, Hirukawa H, Kohara K . Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice. Biochem Biophys Res Commun. 2015; 470(3):772-782. DOI: 10.1016/j.bbrc.2015.10.109. View

Ni Q, Gu Y, Xie Y, Yin Q, Zhang H, Nie A . Raptor regulates functional maturation of murine beta cells. Nat Commun. 2017; 8:15755. PMC: 5472774. DOI: 10.1038/ncomms15755. View

Cyphert H, Walker E, Hang Y, Dhawan S, Haliyur R, Bonatakis L . Examining How the MAFB Transcription Factor Affects Islet β-Cell Function Postnatally. Diabetes. 2018; 68(2):337-348. PMC: 6341297. DOI: 10.2337/db18-0903. View

Ganic E, Johansson J, Bennet H, Fex M, Artner I . Islet-specific monoamine oxidase A and B expression depends on MafA transcriptional activity and is compromised in type 2 diabetes. Biochem Biophys Res Commun. 2015; 468(4):629-35. DOI: 10.1016/j.bbrc.2015.11.002. View

Huang J, Lee S, Hoek P, van der Meulen T, Van R, Huising M . Genetic deletion of Urocortin 3 does not prevent functional maturation of beta cells. J Endocrinol. 2020; 246(1):69-78. PMC: 7286360. DOI: 10.1530/JOE-19-0535. View

Raum J, Gerrish K, Artner I, Henderson E, Guo M, Sussel L . FoxA2, Nkx2.2, and PDX-1 regulate islet beta-cell-specific mafA expression through conserved sequences located between base pairs -8118 and -7750 upstream from the transcription start site. Mol Cell Biol. 2006; 26(15):5735-43. PMC: 1592775. DOI: 10.1128/MCB.00249-06. View

Conrad E, Dai C, Spaeth J, Guo M, Cyphert H, Scoville D . The MAFB transcription factor impacts islet α-cell function in rodents and represents a unique signature of primate islet β-cells. Am J Physiol Endocrinol Metab. 2015; 310(1):E91-E102. PMC: 4675799. DOI: 10.1152/ajpendo.00285.2015. View

10.

Rodriguez-Rodriguez A, Donate-Correa J, Rovira J, Cuesto G, Luis-Ravelo D, Fernandes M . Inhibition of the mTOR pathway: A new mechanism of β cell toxicity induced by tacrolimus. Am J Transplant. 2019; 19(12):3240-3249. DOI: 10.1111/ajt.15483. View

11.

Nishimura W, Oishi H, Funahashi N, Fujiwara T, Takahashi S, Yasuda K . Generation and characterization of MafA-Kusabira Orange mice. Endocr J. 2014; 62(1):37-51. DOI: 10.1507/endocrj.EJ14-0296. View

12.

Butler A, Dhawan S, Hoang J, Cory M, Zeng K, Fritsch H . β-Cell Deficit in Obese Type 2 Diabetes, a Minor Role of β-Cell Dedifferentiation and Degranulation. J Clin Endocrinol Metab. 2015; 101(2):523-32. PMC: 4880126. DOI: 10.1210/jc.2015-3566. View

13.

Xu E, Krentz N, Tan S, Chow S, Tang M, Nian C . SOX4 cooperates with neurogenin 3 to regulate endocrine pancreas formation in mouse models. Diabetologia. 2015; 58(5):1013-23. DOI: 10.1007/s00125-015-3507-x. View

14.

Zhu K, Lai Y, Cao H, Bai X, Liu C, Yan Q . Kindlin-2 modulates MafA and β-catenin expression to regulate β-cell function and mass in mice. Nat Commun. 2020; 11(1):484. PMC: 6981167. DOI: 10.1038/s41467-019-14186-y. View

15.

Sato Y, Inoue M, Yoshizawa T, Yamagata K . Moderate hypoxia induces β-cell dysfunction with HIF-1-independent gene expression changes. PLoS One. 2014; 9(12):e114868. PMC: 4264765. DOI: 10.1371/journal.pone.0114868. View

16.

Hou S, Li C, Huan Y, Liu S, Liu Q, Sun S . Effects of E2HSA, a Long-Acting Glucagon Like Peptide-1 Receptor Agonist, on Glycemic Control and Beta Cell Function in Spontaneous Diabetic db/db Mice. J Diabetes Res. 2015; 2015:817839. PMC: 4553314. DOI: 10.1155/2015/817839. View

17.

Wang Z, York N, Nichols C, Remedi M . Pancreatic β cell dedifferentiation in diabetes and redifferentiation following insulin therapy. Cell Metab. 2014; 19(5):872-82. PMC: 4067979. DOI: 10.1016/j.cmet.2014.03.010. View

18.

Hudish L, Reusch J, Sussel L . β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes. J Clin Invest. 2019; 129(10):4001-4008. PMC: 6763241. DOI: 10.1172/JCI129188. View

19.

El Khattabi I, Sharma A . Preventing p38 MAPK-mediated MafA degradation ameliorates β-cell dysfunction under oxidative stress. Mol Endocrinol. 2013; 27(7):1078-90. PMC: 3706838. DOI: 10.1210/me.2012-1346. View

20.

Pullen T, Rutter G . When less is more: the forbidden fruits of gene repression in the adult β-cell. Diabetes Obes Metab. 2012; 15(6):503-12. DOI: 10.1111/dom.12029. View